Among the novel differentially expressed genes, IPCEF1, F13A1, TPI1, B3GNT5, ATP1A2, FN1, PDGFRA, and GSN are found to be hub genes, and we suggest that these genes could be potential therapeutic targets in GBM disease prognosis. This evidence concerns the gene B3GNT5 and glioblastoma.